ARMS2 and age-related macular degeneration: These results are encouraging, given that the AMD risk, among carriers of the CFH Y402H variant, increased by up to 11-fold, and those with the ARMS2 (LOC387715 A69S) variant carried up to 15-times greater risk [16,17,18,19,20,21,22,23,24,25].